<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458520</url>
  </required_header>
  <id_info>
    <org_study_id>PEDSVAR0049</org_study_id>
    <secondary_id>IRB-44706</secondary_id>
    <nct_id>NCT03458520</nct_id>
  </id_info>
  <brief_title>Pediatric PET/MR Image Registry</brief_title>
  <official_title>Pediatric PET/MR Image Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole
      body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed
      Tomography (CT) imaging for the diagnosis of tumors in children and young adults.
      Sensitivities, specificities and diagnostic accuracies of the different imaging modalities
      will be compared for significant differences.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of tumors</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Number of tumors detected on whole body MRI, PET/MR and (if available) PET/CT scans.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic activity of tumors</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Metabolic activity of tumors determined by Standardized Uptake Values (SUV) on PET/MR and (if available) PET/CT scans.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Soft Tissue</condition>
  <condition>Lymphoma</condition>
  <condition>Osteosarcoma</condition>
  <arm_group>
    <arm_group_label>Image Registry</arm_group_label>
    <description>patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor will receive MR imaging, PET/MR imaging (and if available, PET/CT imaging)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/MR imaging</intervention_name>
    <description>undergo PET/MR imaging</description>
    <arm_group_label>Image Registry</arm_group_label>
    <other_name>positron emission tomography</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MR imaging</intervention_name>
    <description>Undergo MR imaging</description>
    <arm_group_label>Image Registry</arm_group_label>
    <other_name>magnetic resonance imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT imaging</intervention_name>
    <description>Undergo PET/CT imaging</description>
    <arm_group_label>Image Registry</arm_group_label>
    <other_name>computed tomography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric and young adult (&lt;40 years) male or female subjects with proven solid tumors or
        newly diagnosed mass strongly suspected to represent a solid tumor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with proven solid tumors or newly diagnosed mass strongly suspected to
             represent a solid tumor.

          -  We might also include some patients with leukemia if there is concern for a focal
             lesion in any of their organs.

          -  Participant's parents (if participant is under 18) or the participant (if participant
             is 18 years or older) must willingly give written informed consent prior to any image
             transfer to the image registry.

        Exclusion Criteria:

          -  Patient has contraindications for MRI or PET/MR. This includes patients with cardiac
             pacemakers or intracranial vascular clips as well as patients with a blood glucose
             level &gt; 200 mg/dl.

          -  Lack of parental permission (if participant is younger than 18) or lack of informed
             consent (if participant is at least 18 years of age).

          -  Patient has a CNS primary tumor.

          -  Pregnant women and fetuses
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heike Daldrup-Link, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Muehe</last_name>
    <phone>650-720-8601</phone>
    <email>amuehe@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University, School of Medicine</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Muehe</last_name>
      <phone>650-720-8601</phone>
      <email>amuehe@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Heike Daldrup-Link, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteosarcoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

